Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 30 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Hypertension, Pulmonary [Clear All Filters]
Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease..
Heart. 105(6), 465-469.
(2019). How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension..
Expert Rev Cardiovasc Ther. 17(1), 11-18.
(2019). Pregnancy still contraindicated in pulmonary arterial hypertension related to congenital heart disease: True or false?.
Eur J Prev Cardiol. 26(10), 1064-1066.
(2019). Definition and Management of Segmental Pulmonary Hypertension..
J Am Heart Assoc. 7(14),
(2018). Right Atrial Function Predicts Clinical Outcome in Patients with Precapillary Pulmonary Hypertension..
J Am Soc Echocardiogr. 31(10), 1137-1145.
(2018). Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis..
BMC Pulm Med. 16(1), 175.
(2016). A case of balloon pulmonary angioplasty as a palliative therapy in chronic thromboembolic pulmonary hypertension..
Hellenic J Cardiol. 57(5), 363-365.
(2016). Ranolazine as a novel therapy for pulmonary arterial hypertension..
Int J Cardiol. 223, 860-862.
(2016). Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review..
Int J Cardiol. 174(3), 618-23.
(2014). Chronic thromboembolic pulmonary hypertension: do not miss the chance for an early diagnosis..
Am J Case Rep. 15, 378-81.
(2014). Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment..
Drug Des Devel Ther. 8, 1753-63.
(2014).
(2014). Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension..
Anaesth Intensive Care. 41(4), 554-6.
(2013). Pulmonary endarterectomy for thromboembolic pulmonary hypertension..
Hellenic J Cardiol. 54(1), 58-9.
(2013). Successful management of an inadvertent excessive treprostinil overdose..
Drug Des Devel Ther. 7, 161-5.
(2013). Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets..
Curr Pharm Des. 18(11), 1457-64.
(2012). Biomarkers in systemic sclerosis-related pulmonary arterial hypertension..
Curr Vasc Pharmacol. 9(2), 213-9.
(2011). Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension..
Respirology. 16(3), 451-8.
(2011). Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters..
Lung. 189(5), 391-9.
(2011). Pulmonary hypertension in idiopathic pulmonary fibrosis: a review..
Respiration. 82(3), 294-304.
(2011). Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study..
Rheumatol Int. 31(2), 263-7.
(2011). Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis..
Clin Rheumatol. 29(9), 957-64.
(2010). Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension..
Semin Arthritis Rheum. 39(4), 278-84.
(2010). Resolution of nocturnal periodic breathing in pulmonary hypertension after optimal treatment..
Ther Adv Respir Dis. 4(4), 249-51.
(2010). Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature..
Inflamm Allergy Drug Targets. 9(4), 313-8.
(2010).